Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.08
+0.08 (1.33%)
Aug 4, 2026, 2:02 PM EDT - Market open
ARCT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 211.38 | 230.91 | 237.03 | 292.01 | 391.88 | 370.49 |
Cash & Short-Term Investments | 211.38 | 230.91 | 237.03 | 292.01 | 391.88 | 370.49 |
Cash Growth | -2.57% | -2.58% | -18.83% | -25.49% | 5.77% | -19.96% |
Accounts Receivable | 1.34 | 5.56 | 3.97 | 32.06 | 2.76 | 3.37 |
Other Current Assets | 4.16 | 4.97 | 64.98 | 62.52 | 8.69 | 5.1 |
Total Current Assets | 216.88 | 241.45 | 305.98 | 386.59 | 403.33 | 378.96 |
Net Property, Plant & Equipment | 26.5 | 27.82 | 36.21 | 40.93 | 44.96 | 11.26 |
Long-Term Investments | - | - | - | - | - | 0.52 |
Other Long-Term Assets | 2.03 | 1.89 | 1.89 | 1.89 | 2.09 | 2.08 |
Total Assets | 245.41 | 271.15 | 344.07 | 429.4 | 450.39 | 392.81 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.09 | 4.24 | 7.19 | 5.28 | 7.45 | 10.06 |
Accrued Expenses | 22.67 | 23.9 | 38.78 | 31.88 | 30.23 | 23.52 |
Current Portion of Long-Term Debt | - | - | - | - | 60.66 | 22.47 |
Unearned Revenue | 7.61 | 8.25 | 19.51 | 44.83 | 28.65 | 43.48 |
Total Current Liabilities | 34.37 | 36.38 | 65.49 | 81.99 | 126.98 | 99.54 |
Long-Term Debt | - | - | - | - | - | 40.63 |
Long-Term Leases | 19.68 | 20.78 | 25 | 25.91 | 30.22 | 4.5 |
Other Long-Term Liabilities | - | - | 12.6 | 42.99 | 22.88 | 19.93 |
Total Long-Term Liabilities | 19.68 | 20.78 | 37.6 | 68.9 | 53.09 | 65.07 |
Total Liabilities | 54.05 | 57.16 | 103.09 | 150.89 | 180.08 | 164.6 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-in Capital | 732.89 | 728.55 | 689.76 | 646.35 | 608.43 | 575.68 |
Retained Earnings | -541.55 | -514.59 | -448.81 | -367.87 | -338.14 | -347.49 |
Shareholders' Equity | 191.36 | 213.99 | 240.98 | 278.51 | 270.31 | 228.21 |
Total Liabilities & Equity | 245.41 | 271.15 | 344.07 | 429.4 | 450.39 | 392.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 19.68 | 20.78 | 25 | 25.91 | 90.87 | 67.61 |
Net Cash (Debt) | 191.7 | 210.13 | 212.03 | 266.1 | 301.01 | 302.88 |
Net Cash Growth | 7.72% | -0.90% | -20.32% | -11.60% | -0.62% | -31.75% |
Net Cash Per Share | 6.92 | 7.67 | 7.85 | 9.99 | 11.11 | 11.51 |
Book Value | 191.36 | 213.99 | 240.98 | 278.51 | 270.31 | 228.21 |
Book Value Per Share | 6.91 | 7.81 | 8.93 | 10.46 | 9.98 | 8.67 |
Tangible Book Value | 191.36 | 213.99 | 240.98 | 278.51 | 270.31 | 228.21 |
Tangible Book Value Per Share | 6.91 | 7.81 | 8.93 | 10.46 | 9.98 | 8.67 |